KNSA: Kiniksa Pharmaceuticals Company Short-Term Debt
Price action depends on the approval of new indications and patient access to therapy. This GURU.Markets terminal chart for short-term debt burden captured the 0.00 parameter. Financial stability relies on the rare disease treatment ecosystem via Arcalyst, while the gradual revenue growth from its sole orphan drug moves Kiniksa Pharmaceuticals (KNSA) into a safe zone.
Metric breakdowns and analytics for Kiniksa Corp (KNSA)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Kiniksa Pharmaceuticals|KNSA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Kiniksa Pharmaceuticals|KNSA - Company Total Debt|Debt to Book Capitalization Ratio Kiniksa Pharmaceuticals|KNSA - Company Long-Term Liabilities|Company Current Liabilities Kiniksa|Quick Liquidity kiniksa.com
- net income and valuation multiples indicators:
Initial company analysis:KNSA - Kiniksa
This indicator measures obligations with a maturity horizon of up to one year, allowing investors to assess operational liquidity and default risk between quarterly reports. By analyzing the dynamics of the current debt load, one can determine how effectively Kiniksa Pharmaceuticals (KNSA) balances loan servicing with the funding of its research sites for treating rare inflammatory diseases to bring new drugs to market.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CLDX (Celldex)|Short-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Short-Term Debt|veratx.com (VERA) - Company Current Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Short-Term Debt|Company Current Liabilities Pharvaris NV|Company Current Liabilities ABCL|Company Short-Term Debts Tourmaline|Company Short-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Short-Term Indebtedness|Company Short-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Short-Term Debt|ZBIO - Company Short-Term Debt|IMNM - Company Short-Term Debts|GOSS: Company Short-Term Debts|KALV - Short-Term Debt Volume|Company Short-Term Debt Septerna|Company Short-Term Indebtedness PVLA (Pieris Pharma)|Company Short-Term Debts SVRA|Short-Term Debt Volume Rigel Corp|Company Short-Term Debt AnaptysBio, Inc. ANAB|Company Short-Term Debts astriatx.com ATXS|ENGN - Company Short-Term Debt|Short-Term Debt Volume rapt.com RAPT|JBIO: Company Short-Term Debts|Aclaris Therapeutics, Inc (ACRS) - Company Short-Term Debts|Company Current Liabilities KYTX|TLSA: Company Short-Term Loans and Borrowings|Company Short-Term Debt Cabaletta Bio (CABA)|VTYX: Current Liabilities|Company Short-Term Debts THTX (Theratechnologies Inc)|Company Short-Term Loans and Borrowings AVTX|Eledon Pharmaceuticals - Company Short-Term Debts|AGEN - Company Short-Term Debts|Climb Bio (CLYM) - Company Short-Term Debt|zurabio.com - Company Short-Term Loans and Borrowings|Company Short-Term Debt aTyr|Company Current Liabilities Adagene Corp (ADAG)|Company Short-Term Debts IMA|Company Short-Term Debts shattucklabs.com (STTK)|Company Short-Term Debts EQ (Equillium)|CNTB - Company Current Liabilities|Immunic Inc - Company Short-Term Debts|Short-Term Debt Atara Biotherapeutics|IFRX (inflarx.de) - Company Current Liabilities|x4pharma.com (XFOR) - Company Short-Term Debts|Company Current Liabilities ACET|CELU (Celularity Corp) - Amount of Current Liabilities|Company Short-Term Debts INMB|Short-Term Debt Volume Barinthus Biotherapeutics Corp|Company Short-Term Debts KZR (Kezar Life Sciences)|SABS - Company Current Liabilities|Akari Therapeutics Plc - Company Short-Term Debts|ENLV - Company Short-Term Debts|q32bio.com (QTTB) - Company Short-Term Debt|GOVX (GeoVax Corp) - Company Short-Term Debt|Company Short-Term Debt Edesa Biotech, Inc.|ibioinc.com (IBIO) - Short-Term Debt Volume|Company Short-Term Debt Carisma Therapeutics (CARM)|Company Short-Term Debts XTL Biopharmaceuticals Ltd (XTLB)|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|HCWB: Company Short-Term Indebtedness|APVO - Company Short-Term Debt|Short-Term Debt Volume aimimmuno.com AIM|ADTX: Company Short-Term Debts|GRI Bio Inc (GRI) - Company Short-Term Debts|Company Short-Term Debt XORTX|Vyome Therapeutics - Current Liabilities|Company Short-Term Debts REVB|INDP (indaptusrx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Company Short-Term Debts CalciMedica Inc CALI|AFMD - Company Short-Term Debt|Company Short-Term Loans and Borrowings ALLK (Allakos Inc.)|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|ITOS (iTeos Therapeutics, Inc.) - Company Short-Term Debts|Company Short-Term Debts Ocean Biomedical Inc|Company Current Liabilities TCBP (TC BioPharm (Holdings) PLC)|THRD (Third Harmonic Bio Inc) - Company Short-Term Loans and Borrowings